Pharmacyclics (PCYC) Crumbles: Stock Falls by 7.7% - Tale of the Tape


Shutterstock photo

Pharmacyclics Inc. ( PCYC ) saw a big move last session, as the company's shares fell by nearly 8% on the day. The move came on pretty good volume too with far more shares changing hands than in a normal session. This continues the recent downtrend for PCYC, as the stock is now down over 30% since in the past one-month time frame.

This slump shouldn't be too much of a surprise to investors, as the company in the Medical-Drugs industry has seen 2 negative revisions in the past few weeks and its current year earnings consensus has moved lower over the last 30 days. This suggests there may be more trouble down the road. So make sure to keep an eye on this stock going forward to see if this recent slump will continue, as the earnings picture definitely suggests that this might be the case.

PCYC currently has a Zacks Rank #3 (Hold) while its Earnings ESP is negative.

Some better-ranked stocks in the same space include Grifols, S.A. ( GRFS ), ImmunoGen Inc. ( IMGN ) and Questcor Pharmaceuticals, Inc. ( QCOR ). All these stocks carry a Zacks Rank  #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days . Click to get this free report >>

GRIFOLS SA-ADR (GRFS): Free Stock Analysis Report

IMMUNOGEN INC (IMGN): Free Stock Analysis Report

PHARMACYCLICS (PCYC): Free Stock Analysis Report

QUESTCOR PHARMA (QCOR): Free Stock Analysis Report

To read this article on click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

This article appears in: Investing , Investing Ideas , Stocks
More Headlines for: GRFS , IMGN , PCYC , QCOR

More from


Equity Research
Follow on:

Find a Credit Card

Select a credit card product by:
Select an offer:
Data Provided by